A Pan-Cancer Analysis Reveals CLEC5A as a Biomarker for Cancer Immunity and Prognosis.
Chen R, Wu W, Chen SY, Liu ZZ, Wen ZP, Yu J, Zhang LB, Liu Z, Zhang J, Luo P, Zeng WJ, Cheng Q.
Chen R, et al. Among authors: liu zz, liu z.
Front Immunol. 2022 Aug 1;13:831542. doi: 10.3389/fimmu.2022.831542. eCollection 2022.
Front Immunol. 2022.
PMID: 35979347
Free PMC article.